Placebo surgery

PROCEDURE4 trials

Sponsors

Sangamo Therapeutics, Tampere University Hospital, Kuopio University Hospital, Helsinki University Central Hospital

Conditions

Alzheimer's DiseaseCarpal Tunnel SurgeryCarpal Tunnel SyndromeCarpal Tunnel Syndrome (CTS)Triangular Fibrocartilage Complex Injury

Phase 2

Randomized, Controlled Study Evaluating CERE-110 in Subjects With Mild to Moderate Alzheimer's Disease

CompletedNCT00876863

Sangamo TherapeuticsAlzheimer's Disease

Start: 2008-11-30End: 2015-08-13Updated: 2020-12-21

Unknown Phase

Trial Comparing Treatment Strategies in Triangular Fibrocartilage Complex Ruptures

RecruitingNCT04576169

Tampere University HospitalTriangular Fibrocartilage Complex Injury

Start: 2020-10-27End: 2035-03-31Target: 204Updated: 2024-10-09

Carpal Tunnel Release Efficacy Trial

Not yet recruitingNCT06934187

Kuopio University HospitalCarpal Tunnel Surgery, Carpal Tunnel Syndrome (CTS)

Start: 2026-01-31End: 2033-12-31Target: 96Updated: 2025-09-19

Finnish Carpal Tunnel Surgery Study

RecruitingNCT07614425

Helsinki University Central HospitalCarpal Tunnel Syndrome

Start: 2026-06-11End: 2035-12-31Target: 180Updated: 2026-06-03

Related Papers

tREatment of trIaNgular FibrOcaRtilage ComplEx Ruptures (REINFORCER): protocol for randomised, controlled, blinded, efficacy trial of triangular fibrocartilage complex tears

BMJ Open2024-12-01

Adeno-Associated Viral Vector (Serotype 2)–Nerve Growth Factor for Patients With Alzheimer Disease

JAMA Neurology2018-03-26205 citations

Neurotrophic factors: promising candidates in tissue regeneration

Neural Regeneration Research2016-01-0113 citations